-+ 0.00%
-+ 0.00%
-+ 0.00%

CORRECTION: Oncolytics Biotech Launches Up To $75M At-the-Market Equity Offering With Jefferies To Fund Clinical Development And Operations

Benzinga·04/06/2026 20:17:13
Listen to the news


On April 6, 2026, Oncolytics Biotech Inc. (the "Company") entered into an Open Market Sale Agreement (the "Sales Agreement") with Jefferies LLC (the "Agent"), pursuant to which the Company may offer and sell from time to time through or to the agent, acting as agent or principal, shares of the Company's common stock, par value $0.001 per share, having an aggregate offering price of up to $75.0 million (the "Shares").